 American International Group Inc. purchased a new position in Brainstorm Cell Therapeutics Inc NASDAQ:BCLI during the 2nd quarter, HoldingsChannel reports. The firm purchased 16,310 shares of the biotechnology companys stock, valued at approximately 183,000. Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Ameritas Investment Partners ... 